Windon, A. L., Loaiza-Bonilla, A., Jensen, C. E., Randall, M., Morrissette, J. J. D., & Shroff, S. G. (2018). A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma. J Gastrointest Oncol.

Windon, Annika L., Arturo Loaiza-Bonilla, Christopher E. Jensen, Michael Randall, Jennifer J. D. Morrissette, a Stuti G. Shroff. "A KRAS Wild Type Mutational Status Confers a Survival Advantage in Pancreatic Ductal Adenocarcinoma." J Gastrointest Oncol 2018.

Windon, Annika L., et al. "A KRAS Wild Type Mutational Status Confers a Survival Advantage in Pancreatic Ductal Adenocarcinoma." J Gastrointest Oncol 2018.